CEO
Vivax, Brazil
Antonio Massato Makiyama is a Brazilian biomedical engineer and innovator with a strong focus on neurorehabilitation technologies. He holds a degree in Marine Engineering from the University of São Paulo, a PhD in Engineering from the University of Cambridge, and completed postdoctoral research at the Massachusetts Institute of Technology (MIT). He spent several years in the United States working in the biomedical field, where he contributed to the development of advanced robotic rehabilitation systems.
Dr. Makiyama is the co-founder and Chief Technology Officer of Vivax, (www.vivaxbr.com) a São Paulo-based healthtech startup committed to creating accessible, data-driven rehabilitation solutions for individuals recovering from stroke and orthopedic conditions. Under his leadership, Vivax has developed groundbreaking technologies that integrate robotics, digital therapeutics, and patient-centered care models.
He is the developer of the ARM robot, a 33-pound (15 kg) portable robotic system designed for upper and lower limb rehabilitation. The device enables intensive, 3D functional movement therapy enhanced by gamification and real-time feedback, supporting high-repetition, task-specific training. Since its commercialization in 2018, the ARM robot has been deployed in clinical settings across Brazil and has demonstrated promising outcomes, particularly among chronic stroke patients.
With a background that spans engineering, neuroscience, and digital health, Dr. Makiyama remains focused on advancing practical, evidence-informed rehabilitation technologies. At Vivax (www.vivaxbr.com), his work continues to support the thoughtful integration of robotics and digital solutions aimed at improving functional outcomes and broadening access to quality care across diverse settings.
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
